These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1138024)

  • 1. A study of the chelating agent diethylenetriaminepentaacetic acid using selective radioiron probes of reticuloendothelial and parenchymal iron stores.
    Hershko C
    J Lab Clin Med; 1975 Jun; 85(6):913-21. PubMed ID: 1138024
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of iron-chelating agents in an in vivo system: potential usefulness of EHPG, a powerful iron-chelating drug.
    Hershko C; Grady RW; Link G
    Br J Haematol; 1982 Jun; 51(2):251-60. PubMed ID: 7082583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced biliary iron excretion with amphiphilic diethylenetriaminepentaacetic acid.
    Adams PC; Lin E; Barber KR; Grant CW
    Hepatology; 1991 Dec; 14(6):1230-4. PubMed ID: 1959873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of iron chelation in the hypertransfused rat: definition of two alternative pathways of iron mobilization.
    Hershko C; Grady RW; Cerami A
    J Lab Clin Med; 1978 Aug; 92(2):144-51. PubMed ID: 681807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of chelating agents on the distribution and excretion of radioiron in rats].
    Günther R
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(4):405-18. PubMed ID: 4238109
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal.
    Hershko C; Avramovici-Grisaru S; Link G; Gelfand L; Sarel S
    J Lab Clin Med; 1981 Jul; 98(1):99-108. PubMed ID: 7252329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferritin stimulation of hydroxyl radical production by rat liver nuclei.
    Kukiełka E; Cederbaum AI
    Arch Biochem Biophys; 1994 Jan; 308(1):70-7. PubMed ID: 8311476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of the improved iron chelating agents EHPG, HBED and their dimethyl esters.
    Hershko C; Grady RW; Link G
    Haematologia (Budap); 1984; 17(1):25-33. PubMed ID: 6427069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron chelators for clinical use.
    Tilbrook GS; Hider RC
    Met Ions Biol Syst; 1998; 35():691-730. PubMed ID: 9444773
    [No Abstract]   [Full Text] [Related]  

  • 10. The nature of storage iron.
    Kohgo Y; Niitsu Y
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1221-8. PubMed ID: 6762794
    [No Abstract]   [Full Text] [Related]  

  • 11. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
    Zevin S; Link G; Grady RW; Hider RC; Peter HH; Hershko C
    Blood; 1992 Jan; 79(1):248-53. PubMed ID: 1728313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolization of iron by plant cells using O-Trensox, a high-affinity abiotic iron-chelating agent.
    Caris C; Baret P; Beguin C; Serratrice G; Pierre JL; Laulhère JP
    Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):879-85. PubMed ID: 8554534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-transferrin-bound iron and tumor cells.
    Anghileri LJ; Thouvenot P
    Anticancer Res; 1997; 17(4A):2529-33. PubMed ID: 9252675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Iron storage and metabolism in nacrophages and endothelial cells after intravenous administration of colloidal ferric saccharate in man].
    Düllmann J; Wulfhekel U; Hausmann K
    Verh Anat Ges; 1976; (70 Pt 2):971-6. PubMed ID: 1024396
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of serum ferritin and iron concentrations and serum total iron-binding capacity to nonheme iron stores in dogs.
    Weeks BR; Smith JE; Northrop JK
    Am J Vet Res; 1989 Feb; 50(2):198-200. PubMed ID: 2719382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies on the efficacy of chelating agents in experimental iron storage disease in the rat].
    Bohne F; Harmuth-Hoene AE; Weber KM
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(4):409-19. PubMed ID: 4232727
    [No Abstract]   [Full Text] [Related]  

  • 17. New orally active alpha-ketohydroxy pyridine chelators for the treatment of iron overload.
    Kontoghiorghes GJ
    Birth Defects Orig Artic Ser; 1988; 23(5B):97-103. PubMed ID: 3390580
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of ascorbic acid in the turnover of storage iron.
    Roeser HP
    Semin Hematol; 1983 Apr; 20(2):91-100. PubMed ID: 6410511
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo iron mobilisation evaluation of hydroxypyridinones in 59Fe-ferritin-loaded rat model.
    Liu ZD; Lu SL; Hider RC
    Biochem Pharmacol; 1999 Mar; 57(5):559-66. PubMed ID: 9952320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of macromolecular chelating agents on the release of 239Pu and 59Fe from rat alveolar macrophages after phagocytic uptake of 239Pu-59Fe-iron hydroxide colloid.
    Sato H; Bulman RA; Takahashi S; Kubota Y
    Health Phys; 1994 May; 66(5):545-9. PubMed ID: 8175361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.